Abstract:Discovered the phenomenon of dissociated erythrocyte agglutination based on erythrocyte fragments. Established a method to evaluate the functional activity of the complement system by exploiting the dissociation phenomenon of erythrocyte agglutination and using an auto hematology analyzer for combined detection of total complement activity (AC) and complement activators activated complement activity (ACA). The results of this method are highly accurate and reliable. It has the capability to not only screen for diseases but also differentiate between different types of diseases. Objective The objective of the study was to validate the dissociation phenomenon of erythrocyte agglutination which is based on erythrocyte fragments and to apply it in the functional activity assay of the complement system. Methods The dissociation–agglutination effect of erythrocyte fragments was validated by detecting the number of free erythrocytes after the action of erythrocyte fragments on agglutinated erythrocytes. The number of free erythrocytes produced after hemolysis of agglutinated erythrocytes caused by complements and complement activators(CAs) was detected by auto hematology analyzer and the results were indicated by mean hemoglobin concentration of erythrocytes (MCHC). We optimized the test conditions and validated the inter‐batch stability, explored the resolution of the assay method, and assayed for the total complement activity (AC) and the CAs activated complement activity (ACA) in serum from patients and healthy individual groups. Results Erythrocyte fragments have a dissociative effect on agglutinated erythrocytes. The auto hematology analyzer was able to detect AC and ACA, where AC showed an inverse correlation with MCHC, and ACA demonstrated a positive correlation with MCHC. The inter‐batch CV of AC, ACA, and ACA/AC was found to be 5%, 9%, and 11.7%, respectively, with good stability. The study found that serum samples from acute phase reaction patients showed significant differences in ACA compared with healthy individuals, with a p value of 0.018; serum samples from patients with nephrotic syndrome showed significant differences in AC, ACA, and ACA/AC compared with healthy individuals, with p values of 0.014, 0.002, and 0.041, respectively. Conclusion Erythrocyte fragments have dissociation–agglutination effect. The complement system immunological functional detection method, based on this effect, has potential clinical application value due to its sensitivity and accuracy.

Dissociation Phenomenon of Erythrocyte Agglutination and Its Application to Assay of Functional Activity of the Complement System in Clinical Laboratory

A Novel General and Efficient Technique for Dissociating Antigen in Circulating Immune Complexes

Methods for quantitative detection of antibody-induced complement activation on red blood cells

Characterization of red blood cells agglutination based on stochastic collision electrochemical technique

Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma

The effect of hemolysis on 41 chemistry and immunology tests and determination of hemolysis alert index

Detection of Red Blood Cell—Bound Immunoglobulin G by Flow Cytometry and Its Application in the Diagnosis of Autoimmune Hemolytic Anemia

Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort

Comparison of the conventional tube and erythrocyte-magnetized technology in titration of red blood cell alloantibodies

Improved method for fluorescence cytometric immunohematology testing

Clinical application evaluation of chromogenic substrate assay in detecting coagulation factor Ⅷ activity

Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies

Identification of Complement C3f‐desArg and Its Derivative for Acute Leukemia Diagnosis and Minimal Residual Disease Assessment

Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients

Polymer agglutination-based piezoelectric immunoassay for the determination of complement III.

Performance Evaluation of Clinical Detection of Coagulation Factors, Protein S, Protein C, Anti-thrombin Ⅲ, and von Willebrand Factor Antigen

Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis

Empirical study and clinical application on IgG antibody detection with microcolumn gel test and antihuman globulin test

Identification Of A Complement Receptor 1 Peptide For Inhibition Of Immune Hemolysis

Quantification of the Erythrocyte Deformability Using Atomic Force Microscopy: Correlation Study of the Erythrocyte Deformability with Atomic Force Microscopy and Hemorheology

Clinical Utility of Automated Platelet Clump Count in the Screening for Ethylene Diamine Tetraacetic Acid-Dependent Pseudothrombocytopenia.